Frank Haluska, SVP, Clinical R&D, CMO at ARIAD PHARMACEUTICALS INC (ARIA), sold 4,461 shares at $7.89 ($36K) on 2014-03-21, disclosed to the SEC on 2014-03-21.
Scheduled sale ($36k) by SVP, Clinical R&D, CMO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.19 | 2,061 | $17K | 47.1% |
| 2 | $7.89 | 2,400 | $19K | 52.9% |
| Total | $8.03 avg | 4,461 | $36K | 100% |
| Filing → |
| ARIA | SELL | 2016-02-03 | $155K | — | Filing → |
| ARIA | SELL | 2015-09-28 | $36K | — | Filing → |
| ARIA | SELL | 2015-07-16 | $38K | — | Filing → |